Manufacturing Scale Up30 Sep 2021 09:53
RNS Number : 3710A
29 September 2020
“Company has made good progress with discussions with a variety of international suppliers to scale up production of SNG001 rapidly, with the aim of being able to produce approximately 100,000 treatments per month in 2021“
RNS Number : 4655N
30 September 2021
“Company expects to have tens of thousands of treatment courses available to the market should an EUA be granted. With government support, the Company has the potential to increase capacity to approximately 100,000 treatment courses per month”
so government support is required after 12 months, big pharma cannot / will not help out